The Roles of Vitamin D Levels, Gla-Rich Protein , and Inflammatory Markers in Predicting Mortality in Intensive Care Patients: A New Biomarker Link?

Objectives: Identifying reliable biomarkers to predict mortality in critically ill patients is crucial for optimizing management in intensive care units (ICUs). Inflammatory and metabolic markers are increasingly recognized for their prognostic value. This study aims to evaluate the association of v...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Metabolites 2024-11, Vol.14 (11)
Hauptverfasser: Seğmen, Fatih, Aydemir, Semih, Küçük, Onur, Dokuyucu, Recep
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 11
container_start_page
container_title Metabolites
container_volume 14
creator Seğmen, Fatih
Aydemir, Semih
Küçük, Onur
Dokuyucu, Recep
description Objectives: Identifying reliable biomarkers to predict mortality in critically ill patients is crucial for optimizing management in intensive care units (ICUs). Inflammatory and metabolic markers are increasingly recognized for their prognostic value. This study aims to evaluate the association of various inflammatory and metabolic markers with ICU mortality. Methods: This prospective observational study was conducted from January 2023 to January 2024 in the City Hospital’s ICU. A total of 160 critically ill patients were enrolled. Laboratory parameters, including white blood cell (WBC) count, red cell distribution width (RDW), platelet count, neutrophil count, mean platelet volume (MPV), monocyte count, lymphocyte count, procalcitonin (PCT), C-reactive protein (CRP), calcium (Ca[sup.++]), and vitamin D levels, were analyzed. Additionally, ratios such as the platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), systemic inflammatory index (SII), and pan-immune-inflammation value (PIV) were calculated. Plasma levels of Gla-rich protein (GRP) and dephosphorylated uncarboxylated matrix Gla protein (dp-ucMGP) were measured using ELISA. Results: The mean age of the patients included in the study was 60.5 ± 15.8 years. Cardiovascular disease was present in 72 patients (45%), respiratory system disease in 58 (36%), and chronic kidney disease (CKD) in 38 (24%). Additionally, 61 patients (38%) had diabetes, and 68 (42%) had hypertension. Inflammatory markers, including PLR, NLR, and PIV, were all significantly higher in non-survivors, while calcium and vitamin D levels were lower (p < 0.05). Higher WBC, RDW, neutrophil count, PLR, NLR, PIV, CRP, procalcitonin, GRP, and dp-ucMGP levels were positively correlated with longer hospital stays and increased mortality. In contrast, platelet and lymphocyte counts were negatively correlated with both outcomes (p < 0.05). Vitamin D levels showed an inverse relationship with both hospital stay and mortality, indicating that lower levels were associated with worse outcomes (p < 0.05). In multiple logistic regression analysis, elevated WBC count (OR = 1.20, p = 0.02), RDW (OR = 1.35, p = 0.01), neutrophil count (OR = 1.25, p = 0.01), MPV (OR = 1.20, p = 0.02), PLR (OR = 1.30, p = 0.01), NLR (OR = 1.40, p = 0.001), PIV (OR = 1.50, p = 0.001), CRP (OR = 1.32, p = 0.01), procalcitonin (OR = 1.45, p = 0.001), GRP (OR = 1.40, p = 0.001), and dp-ucMGP (OR = 1.30, p = 0.001) levels were significantly associated wit
doi_str_mv 10.3390/metabo14110620
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A818340093</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A818340093</galeid><sourcerecordid>A818340093</sourcerecordid><originalsourceid>FETCH-LOGICAL-g673-507f070109efd3da7f04f7d2222d998252e437de7fe31a74962de845852adb5f3</originalsourceid><addsrcrecordid>eNptT01LAzEQDaJg0V49D3jt1mSzn16kVq2FrZZSvJZ0M2ljdxPYhEr_hz_Y-HHowTeHmXnvzYMh5IrRIeclvWnRi7VlCWM0i-kJ6cUxKyJWFuXp0XxO-s6904CMpjllPfK53CIsbIMOrII37UWrDTxAhXts3AAmjYgWut7CvLMegzQAYSRMjWpE2wpvuwPMRLfDzkFQ5x1KXXttNjCznReN9odvfmo8Gqf3CGPRIcyF12i8u4URvOAH3Gvb_oRApc3u7pKcKdE47P_1C7J8elyOn6PqdTIdj6pok-U8SmmuaHiClqgklyJsicplHCDLsojTGBOeS8wVcibypMxiiUWSFmks5DpV_IJc_8ZuRIMrbZT1nahb7erVqGAFTygteXAN_3GFktjq2hpUOvBHB19z2nfI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Roles of Vitamin D Levels, Gla-Rich Protein , and Inflammatory Markers in Predicting Mortality in Intensive Care Patients: A New Biomarker Link?</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Seğmen, Fatih ; Aydemir, Semih ; Küçük, Onur ; Dokuyucu, Recep</creator><creatorcontrib>Seğmen, Fatih ; Aydemir, Semih ; Küçük, Onur ; Dokuyucu, Recep</creatorcontrib><description>Objectives: Identifying reliable biomarkers to predict mortality in critically ill patients is crucial for optimizing management in intensive care units (ICUs). Inflammatory and metabolic markers are increasingly recognized for their prognostic value. This study aims to evaluate the association of various inflammatory and metabolic markers with ICU mortality. Methods: This prospective observational study was conducted from January 2023 to January 2024 in the City Hospital’s ICU. A total of 160 critically ill patients were enrolled. Laboratory parameters, including white blood cell (WBC) count, red cell distribution width (RDW), platelet count, neutrophil count, mean platelet volume (MPV), monocyte count, lymphocyte count, procalcitonin (PCT), C-reactive protein (CRP), calcium (Ca[sup.++]), and vitamin D levels, were analyzed. Additionally, ratios such as the platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), systemic inflammatory index (SII), and pan-immune-inflammation value (PIV) were calculated. Plasma levels of Gla-rich protein (GRP) and dephosphorylated uncarboxylated matrix Gla protein (dp-ucMGP) were measured using ELISA. Results: The mean age of the patients included in the study was 60.5 ± 15.8 years. Cardiovascular disease was present in 72 patients (45%), respiratory system disease in 58 (36%), and chronic kidney disease (CKD) in 38 (24%). Additionally, 61 patients (38%) had diabetes, and 68 (42%) had hypertension. Inflammatory markers, including PLR, NLR, and PIV, were all significantly higher in non-survivors, while calcium and vitamin D levels were lower (p &lt; 0.05). Higher WBC, RDW, neutrophil count, PLR, NLR, PIV, CRP, procalcitonin, GRP, and dp-ucMGP levels were positively correlated with longer hospital stays and increased mortality. In contrast, platelet and lymphocyte counts were negatively correlated with both outcomes (p &lt; 0.05). Vitamin D levels showed an inverse relationship with both hospital stay and mortality, indicating that lower levels were associated with worse outcomes (p &lt; 0.05). In multiple logistic regression analysis, elevated WBC count (OR = 1.20, p = 0.02), RDW (OR = 1.35, p = 0.01), neutrophil count (OR = 1.25, p = 0.01), MPV (OR = 1.20, p = 0.02), PLR (OR = 1.30, p = 0.01), NLR (OR = 1.40, p = 0.001), PIV (OR = 1.50, p = 0.001), CRP (OR = 1.32, p = 0.01), procalcitonin (OR = 1.45, p = 0.001), GRP (OR = 1.40, p = 0.001), and dp-ucMGP (OR = 1.30, p = 0.001) levels were significantly associated with increased mortality. Conclusions: Inflammatory and metabolic markers, particularly NLR, PLR, PIV, GRP, and dp-ucMGP, are strong predictors of mortality in ICU patients. These markers provide valuable insights for risk stratification and early identification of high-risk patients, potentially guiding more targeted interventions to improve outcomes.</description><identifier>ISSN: 2218-1989</identifier><identifier>EISSN: 2218-1989</identifier><identifier>DOI: 10.3390/metabo14110620</identifier><language>eng</language><publisher>MDPI AG</publisher><subject>Alfacalcidol ; Analysis ; Blood cell count ; C-reactive protein ; Calcifediol ; Chronic kidney failure ; Diagnosis ; Enzyme-linked immunosorbent assay ; Hospital patients ; Illinois ; Inflammation ; Lymphocytes ; Medical research ; Medicine, Experimental ; Mortality ; Patient outcomes ; Prognosis ; Turkey ; Vitamin D</subject><ispartof>Metabolites, 2024-11, Vol.14 (11)</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Seğmen, Fatih</creatorcontrib><creatorcontrib>Aydemir, Semih</creatorcontrib><creatorcontrib>Küçük, Onur</creatorcontrib><creatorcontrib>Dokuyucu, Recep</creatorcontrib><title>The Roles of Vitamin D Levels, Gla-Rich Protein , and Inflammatory Markers in Predicting Mortality in Intensive Care Patients: A New Biomarker Link?</title><title>Metabolites</title><description>Objectives: Identifying reliable biomarkers to predict mortality in critically ill patients is crucial for optimizing management in intensive care units (ICUs). Inflammatory and metabolic markers are increasingly recognized for their prognostic value. This study aims to evaluate the association of various inflammatory and metabolic markers with ICU mortality. Methods: This prospective observational study was conducted from January 2023 to January 2024 in the City Hospital’s ICU. A total of 160 critically ill patients were enrolled. Laboratory parameters, including white blood cell (WBC) count, red cell distribution width (RDW), platelet count, neutrophil count, mean platelet volume (MPV), monocyte count, lymphocyte count, procalcitonin (PCT), C-reactive protein (CRP), calcium (Ca[sup.++]), and vitamin D levels, were analyzed. Additionally, ratios such as the platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), systemic inflammatory index (SII), and pan-immune-inflammation value (PIV) were calculated. Plasma levels of Gla-rich protein (GRP) and dephosphorylated uncarboxylated matrix Gla protein (dp-ucMGP) were measured using ELISA. Results: The mean age of the patients included in the study was 60.5 ± 15.8 years. Cardiovascular disease was present in 72 patients (45%), respiratory system disease in 58 (36%), and chronic kidney disease (CKD) in 38 (24%). Additionally, 61 patients (38%) had diabetes, and 68 (42%) had hypertension. Inflammatory markers, including PLR, NLR, and PIV, were all significantly higher in non-survivors, while calcium and vitamin D levels were lower (p &lt; 0.05). Higher WBC, RDW, neutrophil count, PLR, NLR, PIV, CRP, procalcitonin, GRP, and dp-ucMGP levels were positively correlated with longer hospital stays and increased mortality. In contrast, platelet and lymphocyte counts were negatively correlated with both outcomes (p &lt; 0.05). Vitamin D levels showed an inverse relationship with both hospital stay and mortality, indicating that lower levels were associated with worse outcomes (p &lt; 0.05). In multiple logistic regression analysis, elevated WBC count (OR = 1.20, p = 0.02), RDW (OR = 1.35, p = 0.01), neutrophil count (OR = 1.25, p = 0.01), MPV (OR = 1.20, p = 0.02), PLR (OR = 1.30, p = 0.01), NLR (OR = 1.40, p = 0.001), PIV (OR = 1.50, p = 0.001), CRP (OR = 1.32, p = 0.01), procalcitonin (OR = 1.45, p = 0.001), GRP (OR = 1.40, p = 0.001), and dp-ucMGP (OR = 1.30, p = 0.001) levels were significantly associated with increased mortality. Conclusions: Inflammatory and metabolic markers, particularly NLR, PLR, PIV, GRP, and dp-ucMGP, are strong predictors of mortality in ICU patients. These markers provide valuable insights for risk stratification and early identification of high-risk patients, potentially guiding more targeted interventions to improve outcomes.</description><subject>Alfacalcidol</subject><subject>Analysis</subject><subject>Blood cell count</subject><subject>C-reactive protein</subject><subject>Calcifediol</subject><subject>Chronic kidney failure</subject><subject>Diagnosis</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Hospital patients</subject><subject>Illinois</subject><subject>Inflammation</subject><subject>Lymphocytes</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Mortality</subject><subject>Patient outcomes</subject><subject>Prognosis</subject><subject>Turkey</subject><subject>Vitamin D</subject><issn>2218-1989</issn><issn>2218-1989</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptT01LAzEQDaJg0V49D3jt1mSzn16kVq2FrZZSvJZ0M2ljdxPYhEr_hz_Y-HHowTeHmXnvzYMh5IrRIeclvWnRi7VlCWM0i-kJ6cUxKyJWFuXp0XxO-s6904CMpjllPfK53CIsbIMOrII37UWrDTxAhXts3AAmjYgWut7CvLMegzQAYSRMjWpE2wpvuwPMRLfDzkFQ5x1KXXttNjCznReN9odvfmo8Gqf3CGPRIcyF12i8u4URvOAH3Gvb_oRApc3u7pKcKdE47P_1C7J8elyOn6PqdTIdj6pok-U8SmmuaHiClqgklyJsicplHCDLsojTGBOeS8wVcibypMxiiUWSFmks5DpV_IJc_8ZuRIMrbZT1nahb7erVqGAFTygteXAN_3GFktjq2hpUOvBHB19z2nfI</recordid><startdate>20241101</startdate><enddate>20241101</enddate><creator>Seğmen, Fatih</creator><creator>Aydemir, Semih</creator><creator>Küçük, Onur</creator><creator>Dokuyucu, Recep</creator><general>MDPI AG</general><scope/></search><sort><creationdate>20241101</creationdate><title>The Roles of Vitamin D Levels, Gla-Rich Protein , and Inflammatory Markers in Predicting Mortality in Intensive Care Patients: A New Biomarker Link?</title><author>Seğmen, Fatih ; Aydemir, Semih ; Küçük, Onur ; Dokuyucu, Recep</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g673-507f070109efd3da7f04f7d2222d998252e437de7fe31a74962de845852adb5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Alfacalcidol</topic><topic>Analysis</topic><topic>Blood cell count</topic><topic>C-reactive protein</topic><topic>Calcifediol</topic><topic>Chronic kidney failure</topic><topic>Diagnosis</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Hospital patients</topic><topic>Illinois</topic><topic>Inflammation</topic><topic>Lymphocytes</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Mortality</topic><topic>Patient outcomes</topic><topic>Prognosis</topic><topic>Turkey</topic><topic>Vitamin D</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seğmen, Fatih</creatorcontrib><creatorcontrib>Aydemir, Semih</creatorcontrib><creatorcontrib>Küçük, Onur</creatorcontrib><creatorcontrib>Dokuyucu, Recep</creatorcontrib><jtitle>Metabolites</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seğmen, Fatih</au><au>Aydemir, Semih</au><au>Küçük, Onur</au><au>Dokuyucu, Recep</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Roles of Vitamin D Levels, Gla-Rich Protein , and Inflammatory Markers in Predicting Mortality in Intensive Care Patients: A New Biomarker Link?</atitle><jtitle>Metabolites</jtitle><date>2024-11-01</date><risdate>2024</risdate><volume>14</volume><issue>11</issue><issn>2218-1989</issn><eissn>2218-1989</eissn><abstract>Objectives: Identifying reliable biomarkers to predict mortality in critically ill patients is crucial for optimizing management in intensive care units (ICUs). Inflammatory and metabolic markers are increasingly recognized for their prognostic value. This study aims to evaluate the association of various inflammatory and metabolic markers with ICU mortality. Methods: This prospective observational study was conducted from January 2023 to January 2024 in the City Hospital’s ICU. A total of 160 critically ill patients were enrolled. Laboratory parameters, including white blood cell (WBC) count, red cell distribution width (RDW), platelet count, neutrophil count, mean platelet volume (MPV), monocyte count, lymphocyte count, procalcitonin (PCT), C-reactive protein (CRP), calcium (Ca[sup.++]), and vitamin D levels, were analyzed. Additionally, ratios such as the platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), systemic inflammatory index (SII), and pan-immune-inflammation value (PIV) were calculated. Plasma levels of Gla-rich protein (GRP) and dephosphorylated uncarboxylated matrix Gla protein (dp-ucMGP) were measured using ELISA. Results: The mean age of the patients included in the study was 60.5 ± 15.8 years. Cardiovascular disease was present in 72 patients (45%), respiratory system disease in 58 (36%), and chronic kidney disease (CKD) in 38 (24%). Additionally, 61 patients (38%) had diabetes, and 68 (42%) had hypertension. Inflammatory markers, including PLR, NLR, and PIV, were all significantly higher in non-survivors, while calcium and vitamin D levels were lower (p &lt; 0.05). Higher WBC, RDW, neutrophil count, PLR, NLR, PIV, CRP, procalcitonin, GRP, and dp-ucMGP levels were positively correlated with longer hospital stays and increased mortality. In contrast, platelet and lymphocyte counts were negatively correlated with both outcomes (p &lt; 0.05). Vitamin D levels showed an inverse relationship with both hospital stay and mortality, indicating that lower levels were associated with worse outcomes (p &lt; 0.05). In multiple logistic regression analysis, elevated WBC count (OR = 1.20, p = 0.02), RDW (OR = 1.35, p = 0.01), neutrophil count (OR = 1.25, p = 0.01), MPV (OR = 1.20, p = 0.02), PLR (OR = 1.30, p = 0.01), NLR (OR = 1.40, p = 0.001), PIV (OR = 1.50, p = 0.001), CRP (OR = 1.32, p = 0.01), procalcitonin (OR = 1.45, p = 0.001), GRP (OR = 1.40, p = 0.001), and dp-ucMGP (OR = 1.30, p = 0.001) levels were significantly associated with increased mortality. Conclusions: Inflammatory and metabolic markers, particularly NLR, PLR, PIV, GRP, and dp-ucMGP, are strong predictors of mortality in ICU patients. These markers provide valuable insights for risk stratification and early identification of high-risk patients, potentially guiding more targeted interventions to improve outcomes.</abstract><pub>MDPI AG</pub><doi>10.3390/metabo14110620</doi></addata></record>
fulltext fulltext
identifier ISSN: 2218-1989
ispartof Metabolites, 2024-11, Vol.14 (11)
issn 2218-1989
2218-1989
language eng
recordid cdi_gale_infotracmisc_A818340093
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Alfacalcidol
Analysis
Blood cell count
C-reactive protein
Calcifediol
Chronic kidney failure
Diagnosis
Enzyme-linked immunosorbent assay
Hospital patients
Illinois
Inflammation
Lymphocytes
Medical research
Medicine, Experimental
Mortality
Patient outcomes
Prognosis
Turkey
Vitamin D
title The Roles of Vitamin D Levels, Gla-Rich Protein , and Inflammatory Markers in Predicting Mortality in Intensive Care Patients: A New Biomarker Link?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A36%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Roles%20of%20Vitamin%20D%20Levels,%20Gla-Rich%20Protein%20,%20and%20Inflammatory%20Markers%20in%20Predicting%20Mortality%20in%20Intensive%20Care%20Patients:%20A%20New%20Biomarker%20Link?&rft.jtitle=Metabolites&rft.au=Se%C4%9Fmen,%20Fatih&rft.date=2024-11-01&rft.volume=14&rft.issue=11&rft.issn=2218-1989&rft.eissn=2218-1989&rft_id=info:doi/10.3390/metabo14110620&rft_dat=%3Cgale%3EA818340093%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A818340093&rfr_iscdi=true